Phibro Animal Health (PAHC) Asset Utilization Ratio (2014 - 2026)
Phibro Animal Health's (PAHC) quarterly Asset Utilization Ratio came in at 1.05 in Q1 2026, up 15.03% year-on-year from 0.91 in Q1 2025, and little changed quarter-over-quarter from 1.05 in Q4 2025.
Phibro Animal Health (PAHC) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
Phibro Animal Health's Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 1.05 for Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 15.03% year-over-year to 1.05 in Q1 2026; TTM through Mar 2026 was 1.05, a 15.03% increase from a year earlier, with the FY2025 full-year figure at 1.11, up 6.2% from the prior year.
- Asset Utilization Ratio was little changed at 1.05 in Q1 2026 per PAHC's latest filing, from 1.05 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.07 in Q3 2024 and bottomed at 0.91 in Q1 2025.
- The 5-year median for Asset Utilization Ratio is 1.02 (2025), against an average of 1.02.
- Across the five-year window, Asset Utilization Ratio dropped 10.68% in 2025 and increased 15.03% in 2026, its largest moves.
- Year by year, Asset Utilization Ratio stood at 1.02 in 2022, then retreated by 0.38% to 1.01 in 2023, then retreated by 3.1% to 0.98 in 2024, then gained by 6.81% to 1.05 in 2025, then increased by 0.3% to 1.05 in 2026.
- Per Business Quant, the three latest PAHC Asset Utilization Ratio figures stand at 1.05 (Q1 2026), 1.05 (Q4 2025), and 1.02 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.43 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.62 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.46 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 0.43 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 0.65 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.37 |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 1.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 |
| Dec 31, 2025 | 1.05 |
| Sep 30, 2025 | 1.02 |
| Jun 30, 2025 | 0.97 |
| Mar 31, 2025 | 0.91 |
| Dec 31, 2024 | 0.98 |
| Sep 30, 2024 | 1.07 |
| Jun 30, 2024 | 1.04 |
| Mar 31, 2024 | 1.02 |
| Dec 31, 2023 | 1.01 |
| Sep 30, 2023 | 1.01 |
| Jun 30, 2023 | 1.01 |
| Mar 31, 2023 | 1.02 |
| Dec 31, 2022 | 1.02 |
| Sep 30, 2022 | 1.02 |
| Jun 30, 2022 | 1.02 |
| Mar 31, 2022 | 1.03 |
| Dec 31, 2021 | 1.04 |
| Sep 30, 2021 | 1.02 |
| Jun 30, 2021 | 1.01 |